long-term effects of glp-1 medications Starting a medication? Knowing the common side can help you navigate your health journey smoothly. Tap below to for the full guide: https://bit.ly/4obf3qk GLP-1 diabetes and weight-loss drug

Neurological Health BPC-157 is also evidenced to have neuroprotective effects, reducing nerve damage due to strokes and injuries while regulating neurotransmitters to attenuate symptoms of Parkinsons disease, schizophrenia, and depression [2, 33, 36]

R., Brocato, L., Manzato, E., Berchio, A., Massarenti, P., Settanni, F., Della, Casa L., Bergamini, S., and Iannone, A

Six clinical trials enrolling ~900 participants demonstrated excellent safety but the pivotal Phase IIb trial failed to show clinically meaningful weight loss, leading to development termination in 2007

Clinical trials have shown improvements in liver enzyme levels, hepatic fat content, and markers of liver inflammation in patients treated with these medications